High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group. (Q53965804)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group. |
scientific article |
Statements
High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group (English)
Dmoszyńska A
Hołowiecki J
Skotnicki A
Stella-Hołowiecka B
Robak T
Kuliczkowski K
Czyz J
Hellmann A
Hansz J
Goździk J
Kachel Ł
Knopińska-Posłuszny W
Nagler A
Meder J
Lampka E
Sułek K
Sawicki W
Forgacz K
Suchnicki K
Pacuszko T
Mensah P
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference